Is It Livedoid Vasculopathy or Vasculitis?
At a Glance
Livedoid vasculopathy (LV) is a clotting condition, not an inflammatory disease like vasculitis. In LV, tiny blood clots block the small vessels in the skin, causing painful ulcers. Because it is not driven by inflammation, it is typically treated with blood thinners rather than immunosuppressants.
One of the most confusing parts of being diagnosed with Livedoid Vasculopathy (LV) is its name. Historically, it was often called “livedoid vasculitis,” but medical researchers have since discovered that this name is technically incorrect [1][2]. Understanding the biological difference between vasculopathy and vasculitis is crucial because it determines which treatments will work and which will not.
Vasculopathy vs. Vasculitis: What’s the Difference?
The suffix “-itis” means inflammation. Vasculitis is a condition where the body’s immune system attacks the blood vessel walls, causing them to become inflamed and damaged [2].
Vasculopathy, on the other hand, is a disease of the blood vessels where the primary problem is a thrombo-occlusive event [1][3].
- Thrombo-: Refers to a “thrombus,” or a blood clot.
- Occlusive: Refers to the blockage or closing of a vessel.
In LV, your immune system isn’t primarily attacking your blood vessels. Instead, for reasons doctors are still studying, tiny blood clots (fibrin) form inside the small vessels of your skin [4][5]. These clots act like a “cork in a bottle,” stopping oxygen-rich blood from reaching the skin tissue. This lack of oxygen (ischemia) is what causes the intense pain and the eventual formation of ulcers [3][5].
The Biological “Fingerprint” of LV
When a doctor looks at a sample of your skin under a microscope (a biopsy), they are looking for specific markers that distinguish LV from other conditions:
- Intraluminal Thrombosis: Small clots made of a protein called fibrin found directly inside the blood vessels [4][3].
- Hyaline Degeneration: A thickened, “glassy” appearance of the vessel walls caused by protein deposits [3][5].
- Lack of Inflammation: Unlike vasculitis, a “pure” LV biopsy will not show large numbers of white blood cells (neutrophils) invading the vessel walls [6][3].
Why the Distinction Matters for Treatment
Misdiagnosis is common because LV ulcers can look similar to ulcers caused by inflammation. However, treating LV as if it were an inflammatory vasculitis can lead to frustration and treatment failure [2][7].
| Condition Type | Mechanism | Standard Treatment |
|---|---|---|
| Vasculitis (Inflammatory) | Immune system attacks vessel walls | Immunosuppressants (e.g., Prednisone, Methotrexate) [2] |
| Vasculopathy (Thrombotic/LV) | Blood clots block vessels | Anticoagulants (Blood thinners like Rivaroxaban) [4][8] |
Using immunosuppressants exclusively on LV is often ineffective because these drugs do not stop the blood from clotting [9][2]. This is why many patients only find relief once they switch to a treatment plan focused on “thinning” the blood or preventing new clots from forming [8][10]. (Note: If you have a concurrent autoimmune disorder like Systemic Lupus, your doctor may still prescribe steroids to treat that specific underlying condition).
Common “Look-Alikes”
Because several conditions can cause painful ulcers on the legs, your doctor must rule out other possibilities, including:
- Cutaneous Polyarteritis Nodosa (cPAN): A true vasculitis that affects slightly larger vessels [1][6].
- Pyoderma Gangrenosum: A highly inflammatory condition that causes rapidly growing ulcers with purple, “undermined” edges [11][5].
- Venous Insufficiency: Ulcers caused by poor blood flow in the veins, often associated with varicose veins or swelling [5].
Confirming that your condition is a vasculopathy (a clotting problem) is the key to unlocking the right treatment path and finally finding relief from the pain [11][2].
Common questions in this guide
What is the difference between livedoid vasculopathy and vasculitis?
Why do steroids and other anti-inflammatory drugs fail to heal livedoid vasculopathy?
What will a doctor look for on my skin biopsy?
Can livedoid vasculopathy be confused with other conditions?
What is the main treatment for livedoid vasculopathy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my skin biopsy show 'intraluminal thrombosis' (clotting inside the vessels) or 'inflammatory infiltration' (white blood cells)?
- 2.How does the treatment for LV differ from the treatment for small vessel vasculitis?
- 3.If this isn't primarily an inflammatory condition, why are steroids sometimes used temporarily?
- 4.Are there specific blood tests for 'thrombophilia' (clotting disorders) that we should run to see why my blood is clotting in the skin?
- 5.Could this be a 'look-alike' condition like cutaneous polyarteritis nodosa (cPAN) or pyoderma gangrenosum?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis.
Shakshouk H, Hines A, Kody S, et al.
Journal of the American Academy of Dermatology 2024; (91(6)):1035-1048 doi:10.1016/j.jaad.2024.01.083.
PMID: 38432459 - 2
Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus.
Grinnell M, Bath A, DiMaio D, et al.
Lupus 2019; (28(8)):1013-1016 doi:10.1177/0961203319847274.
PMID: 31126212 - 3
Livedoid vasculopathy: how to diagnose and how to treat?
Lipsker D
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1627-1628 doi:10.1111/jdv.15830.
PMID: 31468610 - 4
Lymphocytic vasculitis in livedoid vasculopathy: A report of 137 cases.
Yuan Y, Liu Y, Ban F, et al.
Journal of cutaneous pathology 2024; (51(2)):155-162 doi:10.1111/cup.14546.
PMID: 37837185 - 5
Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.
Weishaupt C, Strölin A, Kahle B, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1784-1791 doi:10.1111/jdv.15639.
PMID: 31009111 - 6
Three cases of lymphocytic thrombophilic arteritis presenting with an annular eruption.
Kelly RI, Wee E, Tancharoen C, et al.
The Australasian journal of dermatology 2018; (59(2)):e127-e132 doi:10.1111/ajd.12679.
PMID: 28752544 - 7
Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy.
Palanisamy N, Chinnappan J, Bachuwa G
European journal of case reports in internal medicine 2023; (10(1)):003727 doi:10.12890/2023_003727.
PMID: 36819654 - 8
Long-Term Efficacy of Guideline-Followed Treatment in Patients with Livedoid Vasculopathy: A Single-Center Study.
Hillgruber C, Mitschang C, Eveslage M, et al.
Advances in wound care 2025; doi:10.1177/21621918251395013.
PMID: 41264385 - 9
Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.
So BJ, Park JB, Yoo MG, et al.
Annals of dermatology 2015; (27(5)):614-5 doi:10.5021/ad.2015.27.5.614.
PMID: 26512179 - 10
Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a retrospective study.
Zhao C, Yu M, Cheng X, et al.
Clinical and experimental dermatology 2024; (49(8)):817-824 doi:10.1093/ced/llae023.
PMID: 38287670 - 11
A case report and literature review of livedoid vasculopathy in children.
Qu J, Hao Z, Junli W, Yu S
Frontiers in pediatrics 2025; (13()):1537133 doi:10.3389/fped.2025.1537133.
PMID: 40438782
This page explains the medical differences between livedoid vasculopathy and vasculitis for educational purposes. Always consult your dermatologist or healthcare provider for an accurate diagnosis, biopsy interpretation, and personalized treatment plan.
Get notified when new evidence is published on Livedoid vasculopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.